Evidence map›Paper›PMID 42802134›Full record

ReviewActa physiologica (Oxford, England)2026

Renin-Angiotensin Signaling and Vascular Function: Insights into Health and Disease.

Giovanni Bertoldi, Swapnil K Sonkusare

Abstract readReview
In one paragraph

Review in Acta physiologica (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Giovanni BertoldiRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA.ORCID https://orcid.org/0000-0001-6498-6671
Swapnil K SonkusareRobert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA.ORCID https://orcid.org/0000-0001-9587-9342

Funding

Paracrine TNF signaling impairs endothelial TRPV4 microdomains in obesityR01HL142808 · NHLBI · UNIVERSITY OF VIRGINIA · PI Swapnil K. Sonkusare · 2019 to 2026
$4.4M
Flow-Activated Calcium Signaling Microdomains in Small Pulmonary ArteriesR01HL146914 · NHLBI · UNIVERSITY OF VIRGINIA · PI Swapnil K. Sonkusare · 2019 to 2026
$3.8M
Impaired TRVP4-eNOS signaling in TM contributes to glaucomaR01EY034238 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI Swapnil K. Sonkusare, Gulab Zode · 2022 to 2026
$2.2M
Novel Calcium Signaling Nanodomains in Vascular Smooth Muscle CellsR01HL167208 · NHLBI · UNIVERSITY OF VIRGINIA · PI Swapnil K. Sonkusare · 2023 to 2026
$2.1M
NEI NIH HHS R01 EY034238NHLBI NIH HHS R01 HL142808NHLBI NIH HHS R01 HL146914NHLBI NIH HHS R01 HL167208NIH HHS EY034238NIH HHS HL142808NIH HHS HL146914NIH HHS HL167208
6 · The paper itself

Abstract

The renin-angiotensin system (RAS) is an essential regulator of vascular structure and function, and dysregulation of angiotensin II (Ang II) signaling plays a critical role in the development of hypertension and associated vascular complications. Ang II exerts its vascular actions primarily through the angiotensin II type 1 receptor (AT1R), activating canonical and non-canonical signaling pathways that extend beyond classical G-protein-dependent signaling mechanisms. Here, we review the literature on tissue-specific RAS, Ang II-dependent and Ang II-independent signaling mechanisms of vascular Ang II receptors, and their contribution to vasoconstriction, endothelial dysfunction, vascular remodeling, and arterial stiffness in hypertension. We highlight the roles of mechanosensitive AT1R signaling, dysregulation of vascular ion channels, enhanced reactive oxygen species production, immune and inflammatory signaling, and mineralocorticoid receptor activation as key drivers of hypertensive vascular pathology. In addition, we discuss tissue-specific expression of RAS components and separation between RAS pathways underlying blood pressure elevation and vascular remodeling in hypertension. Collectively, emerging research on vascular Ang II receptor signaling reveals novel regulatory mechanisms and therapeutic opportunities beyond conventional RAS inhibition. Targeting downstream pathways that mediate oxidative stress, mechanotransduction, ion channel activity, and profibrotic signaling may offer improved strategies to prevent or reverse Ang II receptor-dependent vascular dysfunction in hypertension.

Indexed as

HypertensionRenin-Angiotensin SystemSignal TransductionAnimalsHumansangiotensin IIangiotensin II receptor 1endothelial cellshypertensionion channelsmineralocorticoid receptorsreactive oxygen speciesvascular remodelingvascular smooth musclevasoconstriction

Identifiers

PMID42802134
PMCPMC13616746

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.